Cargando…
KIAA1522 is a novel prognostic biomarker in patients with non-small cell lung cancer
Nowadays, no robust biomarkers have been applied to clinical practice to provide prognostic evaluation of non-small cell lung cancer (NSCLC). This study aims to identify new potential prognostic biomarkers for NSCLC. In the present work, KIAA1522 is screened out from two independent GEO datasets as...
Autores principales: | Liu, Yi-Zhen, Yang, Hai, Cao, Jian, Jiang, Yan-Yi, Hao, Jia-Jie, Xu, Xin, Cai, Yan, Wang, Ming-Rong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4838871/ https://www.ncbi.nlm.nih.gov/pubmed/27098511 http://dx.doi.org/10.1038/srep24786 |
Ejemplares similares
-
Poor Prognostic Biomarker KIAA1522 Is Associated with Immune Infiltrates in Hepatocellular Carcinoma
por: Shi, Yongjie, et al.
Publicado: (2023) -
Development of novel DNAJB6-KIAA1522-p-mTOR three-protein prognostic prediction models for CRC
por: Jiang, Yu-Juan, et al.
Publicado: (2022) -
The Prognostic Significance of KIAA1522 Expression in Non-Small-Cell Lung Cancer Patients
por: Özdede, Murat, et al.
Publicado: (2023) -
KIAA1522 overexpression promotes tumorigenicity and metastasis of esophageal cancer cells through potentiating the ERK activity
por: Xie, Zhi-Hui, et al.
Publicado: (2017) -
High KIAA1522 expression predicts a poor prognosis in patients with hepatocellular carcinoma
por: Xu, Yongzheng, et al.
Publicado: (2020)